Evidence map›Paper›PMID 40611275›Full record

ArticleImmunity & ageing : I & A2025

Different CMV-specific effector T cell subtypes are associated with age, CMV serostatus, and increased systolic blood pressure.

Lennart M Roesner, Berislav Bošnjak, Stephan Traidl, Jochen Huehn, Reinhold Förster, Thomas Werfel

Abstract read
In one paragraph

Article in Immunity & ageing : I & A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lennart M RoesnerDepartment of Dermatology and Allergy, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, 30625, Hannover, Germany. roesner.lennart@mh-hannover.de.ORCID http://orcid.org/0000-0001-6651-0458
Berislav BošnjakInstitute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Stephan TraidlDepartment of Dermatology and Allergy, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Jochen HuehnDepartment Experimental Immunology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Reinhold FörsterInstitute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Thomas WerfelDepartment of Dermatology and Allergy, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCytomegalovirus (CMV) infection is one of the most common infections in humans, and CMV antigens are the major drivers of repetitive T-cell stimulation as a part of a well-adapted immune response in immunocompetent individuals. With higher age, the recurrent clonal expansion of CMV-specific T cells results in high frequencies of CMV-specific effector T cells. Further on, CMV seropositivity has been linked to an increased risk of developing cardiovascular diseases (CVD). Here we investigated the frequency and phenotype of CMV-specific T cells in the circulation of a population cohort of 650 individuals focusing on the age group over 60 years. Circulating immune cells of individuals carrying the HLA-A*02 allele were investigated (n = 302) applying MHC class I tetramers.

resultsWe add to previous knowledge by showing that the frequency of CMVpp65-specific CD8

conclusionsWithin the circulating CMV-specific T cell population, different effector T-cell subtypes were associated with age, serostatus and SBP. This suggests that it is not age or infection per se that render CMV-positive individuals susceptible to CVD, but rather the cellular immune response to CMV. Detailed immunophenotyping may identify individuals whose immune systems are strongly influenced by the response to CMV, leading to health consequences and impairing healthy aging.

Identifiers

PMID40611275
PMCPMC12224750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.